nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinolazepam—GABRR3—peripheral nervous system—Parkinson's disease	0.0283	0.0582	CbGeAlD
Cinolazepam—GABRR2—peripheral nervous system—Parkinson's disease	0.0245	0.0505	CbGeAlD
Cinolazepam—GABRR1—peripheral nervous system—Parkinson's disease	0.0236	0.0486	CbGeAlD
Cinolazepam—GABRR3—nerve—Parkinson's disease	0.0221	0.0454	CbGeAlD
Cinolazepam—GABRR2—nerve—Parkinson's disease	0.0191	0.0394	CbGeAlD
Cinolazepam—GABRR1—nerve—Parkinson's disease	0.0184	0.0379	CbGeAlD
Cinolazepam—GABRB2—hindbrain—Parkinson's disease	0.00845	0.0174	CbGeAlD
Cinolazepam—GABRA2—hindbrain—Parkinson's disease	0.00772	0.0159	CbGeAlD
Cinolazepam—GABRR1—forebrain—Parkinson's disease	0.00763	0.0157	CbGeAlD
Cinolazepam—GABRA1—hindbrain—Parkinson's disease	0.00746	0.0153	CbGeAlD
Cinolazepam—GABRD—forebrain—Parkinson's disease	0.00663	0.0136	CbGeAlD
Cinolazepam—GABRG1—forebrain—Parkinson's disease	0.00638	0.0131	CbGeAlD
Cinolazepam—GABRA5—forebrain—Parkinson's disease	0.00616	0.0127	CbGeAlD
Cinolazepam—GABRR3—head—Parkinson's disease	0.00524	0.0108	CbGeAlD
Cinolazepam—GABRR3—nervous system—Parkinson's disease	0.00496	0.0102	CbGeAlD
Cinolazepam—GABRB2—brainstem—Parkinson's disease	0.00484	0.00996	CbGeAlD
Cinolazepam—GABRD—medulla oblongata—Parkinson's disease	0.00479	0.00986	CbGeAlD
Cinolazepam—GABRG2—forebrain—Parkinson's disease	0.00467	0.00961	CbGeAlD
Cinolazepam—GABRB2—forebrain—Parkinson's disease	0.00467	0.00961	CbGeAlD
Cinolazepam—GABRG1—medulla oblongata—Parkinson's disease	0.00461	0.00949	CbGeAlD
Cinolazepam—GABRG3—head—Parkinson's disease	0.00459	0.00943	CbGeAlD
Cinolazepam—GABRR2—head—Parkinson's disease	0.00454	0.00934	CbGeAlD
Cinolazepam—GABRB1—medulla oblongata—Parkinson's disease	0.00447	0.0092	CbGeAlD
Cinolazepam—GABRA2—brainstem—Parkinson's disease	0.00442	0.0091	CbGeAlD
Cinolazepam—GABRD—midbrain—Parkinson's disease	0.00438	0.00901	CbGeAlD
Cinolazepam—GABRR1—head—Parkinson's disease	0.00437	0.00899	CbGeAlD
Cinolazepam—GABRG3—nervous system—Parkinson's disease	0.00435	0.00894	CbGeAlD
Cinolazepam—GABRR2—nervous system—Parkinson's disease	0.0043	0.00885	CbGeAlD
Cinolazepam—GABRA1—brainstem—Parkinson's disease	0.00428	0.00879	CbGeAlD
Cinolazepam—GABRA2—forebrain—Parkinson's disease	0.00427	0.00878	CbGeAlD
Cinolazepam—GABRG1—midbrain—Parkinson's disease	0.00422	0.00867	CbGeAlD
Cinolazepam—GABRG3—central nervous system—Parkinson's disease	0.00419	0.00861	CbGeAlD
Cinolazepam—GABRR1—nervous system—Parkinson's disease	0.00414	0.00852	CbGeAlD
Cinolazepam—GABRA1—forebrain—Parkinson's disease	0.00413	0.00849	CbGeAlD
Cinolazepam—GABRG1—spinal cord—Parkinson's disease	0.00411	0.00846	CbGeAlD
Cinolazepam—GABRB1—midbrain—Parkinson's disease	0.00409	0.00841	CbGeAlD
Cinolazepam—GABRR2—cerebellum—Parkinson's disease	0.00405	0.00833	CbGeAlD
Cinolazepam—GABRR1—central nervous system—Parkinson's disease	0.00399	0.00821	CbGeAlD
Cinolazepam—GABRB1—spinal cord—Parkinson's disease	0.00399	0.00821	CbGeAlD
Cinolazepam—GABRD—head—Parkinson's disease	0.0038	0.00781	CbGeAlD
Cinolazepam—GABRG1—head—Parkinson's disease	0.00366	0.00752	CbGeAlD
Cinolazepam—GABRD—nervous system—Parkinson's disease	0.0036	0.00741	CbGeAlD
Cinolazepam—GABRB3—forebrain—Parkinson's disease	0.00359	0.00738	CbGeAlD
Cinolazepam—GABRB1—head—Parkinson's disease	0.00354	0.00729	CbGeAlD
Cinolazepam—GABRA5—head—Parkinson's disease	0.00353	0.00725	CbGeAlD
Cinolazepam—GABRD—central nervous system—Parkinson's disease	0.00347	0.00713	CbGeAlD
Cinolazepam—GABRG1—nervous system—Parkinson's disease	0.00347	0.00713	CbGeAlD
Cinolazepam—GABRD—cerebellum—Parkinson's disease	0.00339	0.00697	CbGeAlD
Cinolazepam—GABRG2—medulla oblongata—Parkinson's disease	0.00338	0.00695	CbGeAlD
Cinolazepam—GABRB2—medulla oblongata—Parkinson's disease	0.00338	0.00695	CbGeAlD
Cinolazepam—GABRB1—nervous system—Parkinson's disease	0.00336	0.00691	CbGeAlD
Cinolazepam—GABRA5—nervous system—Parkinson's disease	0.00334	0.00688	CbGeAlD
Cinolazepam—GABRG1—central nervous system—Parkinson's disease	0.00334	0.00686	CbGeAlD
Cinolazepam—GABRG3—brain—Parkinson's disease	0.00332	0.00684	CbGeAlD
Cinolazepam—GABRA3—head—Parkinson's disease	0.00328	0.00675	CbGeAlD
Cinolazepam—GABRG1—cerebellum—Parkinson's disease	0.00326	0.00671	CbGeAlD
Cinolazepam—GABRB1—central nervous system—Parkinson's disease	0.00324	0.00666	CbGeAlD
Cinolazepam—GABRA5—central nervous system—Parkinson's disease	0.00322	0.00662	CbGeAlD
Cinolazepam—GABRP—head—Parkinson's disease	0.00318	0.00653	CbGeAlD
Cinolazepam—GABRR1—brain—Parkinson's disease	0.00317	0.00651	CbGeAlD
Cinolazepam—GABRB1—cerebellum—Parkinson's disease	0.00316	0.00651	CbGeAlD
Cinolazepam—GABRA3—nervous system—Parkinson's disease	0.00311	0.0064	CbGeAlD
Cinolazepam—GABRG2—midbrain—Parkinson's disease	0.00309	0.00635	CbGeAlD
Cinolazepam—GABRB2—midbrain—Parkinson's disease	0.00309	0.00635	CbGeAlD
Cinolazepam—GABRB2—spinal cord—Parkinson's disease	0.00301	0.00619	CbGeAlD
Cinolazepam—GABRG2—spinal cord—Parkinson's disease	0.00301	0.00619	CbGeAlD
Cinolazepam—GABRA3—central nervous system—Parkinson's disease	0.003	0.00616	CbGeAlD
Cinolazepam—GABRA1—medulla oblongata—Parkinson's disease	0.00298	0.00613	CbGeAlD
Cinolazepam—GABRD—brain—Parkinson's disease	0.00275	0.00566	CbGeAlD
Cinolazepam—GABRA1—midbrain—Parkinson's disease	0.00272	0.00561	CbGeAlD
Cinolazepam—GABRG2—head—Parkinson's disease	0.00268	0.0055	CbGeAlD
Cinolazepam—GABRB2—head—Parkinson's disease	0.00268	0.0055	CbGeAlD
Cinolazepam—GABRA1—spinal cord—Parkinson's disease	0.00266	0.00547	CbGeAlD
Cinolazepam—GABRG1—brain—Parkinson's disease	0.00265	0.00545	CbGeAlD
Cinolazepam—GABRB3—medulla oblongata—Parkinson's disease	0.00259	0.00533	CbGeAlD
Cinolazepam—GABRB1—brain—Parkinson's disease	0.00257	0.00528	CbGeAlD
Cinolazepam—GABRA5—brain—Parkinson's disease	0.00256	0.00526	CbGeAlD
Cinolazepam—GABRG2—nervous system—Parkinson's disease	0.00254	0.00522	CbGeAlD
Cinolazepam—GABRB2—nervous system—Parkinson's disease	0.00254	0.00522	CbGeAlD
Cinolazepam—GABRA2—head—Parkinson's disease	0.00244	0.00503	CbGeAlD
Cinolazepam—GABRB2—central nervous system—Parkinson's disease	0.00244	0.00502	CbGeAlD
Cinolazepam—GABRG2—central nervous system—Parkinson's disease	0.00244	0.00502	CbGeAlD
Cinolazepam—GABRE—head—Parkinson's disease	0.00242	0.00499	CbGeAlD
Cinolazepam—GABRG2—cerebellum—Parkinson's disease	0.00239	0.00491	CbGeAlD
Cinolazepam—GABRB2—cerebellum—Parkinson's disease	0.00239	0.00491	CbGeAlD
Cinolazepam—GABRA3—brain—Parkinson's disease	0.00238	0.00489	CbGeAlD
Cinolazepam—GABRB3—midbrain—Parkinson's disease	0.00237	0.00487	CbGeAlD
Cinolazepam—GABRA1—head—Parkinson's disease	0.00236	0.00486	CbGeAlD
Cinolazepam—GABRA2—nervous system—Parkinson's disease	0.00232	0.00477	CbGeAlD
Cinolazepam—GABRB3—spinal cord—Parkinson's disease	0.00231	0.00476	CbGeAlD
Cinolazepam—GABRE—nervous system—Parkinson's disease	0.0023	0.00473	CbGeAlD
Cinolazepam—GABRA1—nervous system—Parkinson's disease	0.00224	0.00461	CbGeAlD
Cinolazepam—GABRA2—central nervous system—Parkinson's disease	0.00223	0.00459	CbGeAlD
Cinolazepam—GABRE—central nervous system—Parkinson's disease	0.00221	0.00455	CbGeAlD
Cinolazepam—GABRA2—cerebellum—Parkinson's disease	0.00218	0.00449	CbGeAlD
Cinolazepam—GABRA1—central nervous system—Parkinson's disease	0.00216	0.00444	CbGeAlD
Cinolazepam—GABRA1—cerebellum—Parkinson's disease	0.00211	0.00434	CbGeAlD
Cinolazepam—GABRB3—head—Parkinson's disease	0.00205	0.00423	CbGeAlD
Cinolazepam—GABRB3—nervous system—Parkinson's disease	0.00195	0.00401	CbGeAlD
Cinolazepam—GABRB2—brain—Parkinson's disease	0.00194	0.00399	CbGeAlD
Cinolazepam—GABRG2—brain—Parkinson's disease	0.00194	0.00399	CbGeAlD
Cinolazepam—GABRB3—central nervous system—Parkinson's disease	0.00188	0.00386	CbGeAlD
Cinolazepam—GABRB3—cerebellum—Parkinson's disease	0.00183	0.00377	CbGeAlD
Cinolazepam—GABRA2—brain—Parkinson's disease	0.00177	0.00364	CbGeAlD
Cinolazepam—GABRE—brain—Parkinson's disease	0.00176	0.00361	CbGeAlD
Cinolazepam—GABRA1—brain—Parkinson's disease	0.00171	0.00352	CbGeAlD
Cinolazepam—Chlorprothixene—DRD3—Parkinson's disease	0.00159	0.145	CrCbGaD
Cinolazepam—Chlorprothixene—DRD1—Parkinson's disease	0.00156	0.142	CrCbGaD
Cinolazepam—GABRB3—brain—Parkinson's disease	0.00149	0.00306	CbGeAlD
Cinolazepam—Flunitrazepam—CYP2E1—Parkinson's disease	0.00123	0.112	CrCbGaD
Cinolazepam—Chlorprothixene—DRD2—Parkinson's disease	0.0011	0.1	CrCbGaD
Cinolazepam—Flurazepam—CYP2E1—Parkinson's disease	0.000989	0.09	CrCbGaD
Cinolazepam—Midazolam—CYP2E1—Parkinson's disease	0.000917	0.0834	CrCbGaD
Cinolazepam—Chlorprothixene—HTR2A—Parkinson's disease	0.00085	0.0773	CrCbGaD
Cinolazepam—Diazepam—CYP2E1—Parkinson's disease	0.000786	0.0715	CrCbGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000703	0.0014	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—GRIN2B—Parkinson's disease	0.000701	0.00139	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000699	0.00139	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—HSPA8—Parkinson's disease	0.000697	0.00139	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000695	0.00138	CbGpPWpGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000694	0.00138	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000692	0.00138	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000688	0.00137	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—GRIK2—Parkinson's disease	0.000688	0.00137	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000687	0.00137	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—DLG4—Parkinson's disease	0.000686	0.00136	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000677	0.00135	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000677	0.00135	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000675	0.00134	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000675	0.00134	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000671	0.00133	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—GRIN2B—Parkinson's disease	0.00067	0.00133	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000668	0.00133	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—GRIK2—Parkinson's disease	0.000668	0.00133	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000667	0.00133	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—SLC18A2—Parkinson's disease	0.000666	0.00132	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—SLC6A3—Parkinson's disease	0.00066	0.00131	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000656	0.0013	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—GRIK2—Parkinson's disease	0.000656	0.0013	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000656	0.0013	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000656	0.0013	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—DLG4—Parkinson's disease	0.000654	0.0013	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—SLC18A2—Parkinson's disease	0.000647	0.00129	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—GRIK1—Parkinson's disease	0.000647	0.00129	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000646	0.00128	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000645	0.00128	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—GRIK2—Parkinson's disease	0.000645	0.00128	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000644	0.00128	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000644	0.00128	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000641	0.00127	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—GRIK2—Parkinson's disease	0.00064	0.00127	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—GRIN2B—Parkinson's disease	0.000639	0.00127	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000636	0.00126	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—SLC18A2—Parkinson's disease	0.000635	0.00126	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000633	0.00126	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000633	0.00126	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000631	0.00125	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—SLC6A3—Parkinson's disease	0.00063	0.00125	CbGpPWpGaD
Cinolazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000629	0.00125	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000629	0.00125	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—GRIK2—Parkinson's disease	0.000629	0.00125	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000628	0.00125	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000628	0.00125	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—CHRNA4—Parkinson's disease	0.000626	0.00125	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—SLC18A2—Parkinson's disease	0.000624	0.00124	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—SLC18A2—Parkinson's disease	0.00062	0.00123	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000617	0.00123	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000617	0.00123	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—CHRNA4—Parkinson's disease	0.000617	0.00123	CbGpPWpGaD
Cinolazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000615	0.00122	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000613	0.00122	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—SLC18A2—Parkinson's disease	0.000609	0.00121	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000602	0.0012	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000592	0.00118	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000591	0.00118	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000587	0.00117	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000578	0.00115	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000577	0.00115	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000576	0.00114	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000575	0.00114	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—HSPA8—Parkinson's disease	0.000574	0.00114	CbGpPWpGaD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000572	0.00114	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00057	0.00113	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000567	0.00113	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—HSPA8—Parkinson's disease	0.000565	0.00112	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000564	0.00112	CbGpPWpGaD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000563	0.00112	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—BDNF—Parkinson's disease	0.000562	0.00112	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000562	0.00112	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—COMT—Parkinson's disease	0.000562	0.00112	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—MAOA—Parkinson's disease	0.000558	0.00111	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000556	0.00111	CbGpPWpGaD
Cinolazepam—Chlorprothixene—ABCB1—Parkinson's disease	0.000555	0.0505	CrCbGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000555	0.0011	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000554	0.0011	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000552	0.0011	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000551	0.0011	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00055	0.00109	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—GRIK2—Parkinson's disease	0.00055	0.00109	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000544	0.00108	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000542	0.00108	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000542	0.00108	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000541	0.00108	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000539	0.00107	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000539	0.00107	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000539	0.00107	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—DLG4—Parkinson's disease	0.000539	0.00107	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—COMT—Parkinson's disease	0.000536	0.00107	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000534	0.00106	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—SLC18A2—Parkinson's disease	0.000532	0.00106	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—MAOA—Parkinson's disease	0.000532	0.00106	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000531	0.00106	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—DLG4—Parkinson's disease	0.000531	0.00105	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000529	0.00105	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—CHRNA4—Parkinson's disease	0.000527	0.00105	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—GRIN2B—Parkinson's disease	0.000526	0.00105	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000521	0.00104	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—SLC6A3—Parkinson's disease	0.000519	0.00103	CbGpPWpGaD
Cinolazepam—Flurazepam—ABCB1—Parkinson's disease	0.000519	0.0472	CrCbGaD
Cinolazepam—GABRB1—Neuronal System—GRIN2B—Parkinson's disease	0.000519	0.00103	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000517	0.00103	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—CHRNA4—Parkinson's disease	0.000512	0.00102	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—SLC6A3—Parkinson's disease	0.000511	0.00102	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000504	0.001	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—CHRNA4—Parkinson's disease	0.000503	0.001	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—NGF—Parkinson's disease	0.000499	0.000993	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000498	0.000991	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—CHRNA4—Parkinson's disease	0.000494	0.000983	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—CHRNA4—Parkinson's disease	0.000491	0.000976	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000485	0.000964	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—HSPA8—Parkinson's disease	0.000483	0.000961	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—CHRNA4—Parkinson's disease	0.000482	0.000959	CbGpPWpGaD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000481	0.000957	CbGpPWpGaD
Cinolazepam—Midazolam—ABCB1—Parkinson's disease	0.000481	0.0437	CrCbGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000475	0.000945	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000473	0.000941	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000471	0.000936	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—HSPA8—Parkinson's disease	0.000469	0.000933	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000469	0.000933	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000468	0.00093	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000462	0.000919	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000462	0.000919	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—HSPA8—Parkinson's disease	0.000461	0.000916	CbGpPWpGaD
Cinolazepam—GABRA3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000459	0.000913	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000456	0.000906	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000454	0.000903	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—DLG4—Parkinson's disease	0.000453	0.000901	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—HSPA8—Parkinson's disease	0.000453	0.000901	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000453	0.0009	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000451	0.000898	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000451	0.000897	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—HSPA8—Parkinson's disease	0.00045	0.000895	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000448	0.000891	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000443	0.000881	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—GRIN2B—Parkinson's disease	0.000443	0.000881	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—HSPA8—Parkinson's disease	0.000442	0.000879	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—COMT—Parkinson's disease	0.000441	0.000877	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—DLG4—Parkinson's disease	0.00044	0.000876	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00044	0.000875	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—MAOA—Parkinson's disease	0.000438	0.000871	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—SLC6A3—Parkinson's disease	0.000437	0.000868	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—COMT—Parkinson's disease	0.000435	0.000864	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—DLG4—Parkinson's disease	0.000433	0.00086	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—MAOA—Parkinson's disease	0.000431	0.000858	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—GRIN2B—Parkinson's disease	0.00043	0.000856	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000425	0.000846	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—DLG4—Parkinson's disease	0.000425	0.000845	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—SLC6A3—Parkinson's disease	0.000424	0.000844	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—GRIN2B—Parkinson's disease	0.000423	0.000841	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—DLG4—Parkinson's disease	0.000422	0.00084	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	0.000421	0.000838	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000419	0.000833	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—SLC6A3—Parkinson's disease	0.000417	0.000828	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—GRIN2B—Parkinson's disease	0.000415	0.000826	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—DLG4—Parkinson's disease	0.000415	0.000825	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—GRIN2B—Parkinson's disease	0.000413	0.000821	CbGpPWpGaD
Cinolazepam—Diazepam—ABCB1—Parkinson's disease	0.000412	0.0375	CrCbGaD
Cinolazepam—GABRA2—Neuronal System—SLC6A3—Parkinson's disease	0.000409	0.000814	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—SLC6A3—Parkinson's disease	0.000407	0.000809	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—GRIN2B—Parkinson's disease	0.000405	0.000806	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000402	0.000799	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—SLC6A3—Parkinson's disease	0.000399	0.000794	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000391	0.000778	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000387	0.00077	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000386	0.000768	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000386	0.000767	CbGpPWpGaD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000385	0.000765	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000383	0.000761	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—COMT—Parkinson's disease	0.000371	0.000738	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—MAOA—Parkinson's disease	0.000369	0.000733	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.000362	0.000721	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—COMT—Parkinson's disease	0.000361	0.000717	CbGpPWpGaD
Cinolazepam—GABRA5—Neuronal System—MAOA—Parkinson's disease	0.000358	0.000712	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000358	0.000712	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000355	0.000706	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000354	0.000704	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—COMT—Parkinson's disease	0.000354	0.000704	CbGpPWpGaD
Cinolazepam—GABRA3—Neuronal System—MAOA—Parkinson's disease	0.000352	0.000699	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.000349	0.000694	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—COMT—Parkinson's disease	0.000348	0.000692	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000348	0.000692	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—COMT—Parkinson's disease	0.000346	0.000688	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—MAOA—Parkinson's disease	0.000346	0.000687	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—MAOA—Parkinson's disease	0.000343	0.000683	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000342	0.000679	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000341	0.000678	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—COMT—Parkinson's disease	0.00034	0.000675	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000339	0.000674	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—MAOA—Parkinson's disease	0.000337	0.000671	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000336	0.000668	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000334	0.000663	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00033	0.000655	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000327	0.000651	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000325	0.000647	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00032	0.000637	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000314	0.000625	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000309	0.000614	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000307	0.00061	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000301	0.000599	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—COMT—Parkinson's disease	0.000297	0.00059	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000296	0.000589	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.000295	0.000586	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000286	0.000569	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000284	0.000566	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000283	0.000562	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	0.000281	0.000559	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000279	0.000555	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000275	0.000546	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000271	0.00054	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000268	0.000533	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000264	0.000525	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000263	0.000524	CbGpPWpGaD
Cinolazepam—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000258	0.000514	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000235	0.000467	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000233	0.000463	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000229	0.000456	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000228	0.000454	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000227	0.000451	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000226	0.00045	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000225	0.000448	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000224	0.000445	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000223	0.000444	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00022	0.000438	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00022	0.000438	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000219	0.000435	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000219	0.000435	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000215	0.000428	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000215	0.000427	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000211	0.00042	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00021	0.000418	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000206	0.00041	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000196	0.00039	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00019	0.000379	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000188	0.000374	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000188	0.000373	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000187	0.000372	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000184	0.000365	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000183	0.000363	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000183	0.000363	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00018	0.000358	CbGpPWpGaD
Cinolazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000179	0.000357	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000179	0.000356	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000176	0.000351	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000175	0.000348	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000172	0.000342	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000165	0.000327	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000157	0.000312	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00015	0.000299	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000133	0.000264	CbGpPWpGaD
